(1)Biotech: Some CRL Recipients to Considerhttp://seekingalpha.com/article/270094-biotech-some-crl-recipients-to-consider?source=yahoo(2) Wall Street's Best Hidden Stockshttp://www.fool.com/investing/general/2011/06/06/wall-streets-best-hidden-stocks.aspx(3) Top Stocks that others ignore and Wall Street turns a blind eyehttp://markets.financialcontent.com/pennwell.ogj/news/read?GUID=18698965(4) Your Best Small Cap Bets From Herehttp://www.smallcapnetwork.com/Your-Best-Small-Cap-Bets-From-Here-PTIE-ALXA-and-ORS/s/via/10/article/view/p/mid/3/id/5/(5) 3 Top Stocks at Half-Pricehttp://www.fool.com/investing/general/2011/06/21/3-top-stocks-at-half-price.aspx(6) 12 Rallying Stocks Under $5 Undervalued by Analystshttp://seekingalpha.com/article/276585-12-rallying-stocks-under-5-undervalued-by-analysts?source=yahoo(7) Biotech Catalysts for Third Quarterhttp://seekingalpha.com/article/276594-biotech-catalysts-for-third-quarter?source=yahooIt has very cheapest price now.
correct. no use in day trading.
yeah.. it will happen when the news hit the street. Given all the potential and upcoming catalysts.. No use in day trading.
sec70streetBittymac would be proud of you !!! :-D
Me too. Where's ip? No doubt, Mr. King is one of the very smart CEO in pharma world. Its still very cheap at this level provided a 400-500m market worth of drug is going to NDA in 2-3 weeks time. I wish it will go with the partnership.
woov. sure a good one.